16q12.2q21 deletion: A newly recognized cause of dystonia related to GNAO1 haploinsufficiency
- 7 September 2022
- journal article
- editorial
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 103, 112-114
Abstract
No abstract availableKeywords
Funding Information
- Instituto de Salud Carlos III (PI 18/01319, PI21/00248)
This publication has 8 references indexed in Scilit:
- Neurodevelopmental Gene‐Related Dystonia‐Parkinsonism with Onset in Adults: A Case with NAA15 VariantMovement Disorders, 2022
- Highlighting the Dystonic Phenotype Related to GNAO1Movement Disorders, 2022
- Caenorhabditis elegans provides an efficient drug screening platform for GNAO1-related disorders and highlights the potential role of caffeine in controlling dyskinesiaHuman Molecular Genetics, 2021
- Monogenic variants in dystonia: an exome-wide sequencing studyThe Lancet Neurology, 2020
- Two cases of 16q12.1q21 deletions and refinement of the critical regionEuropean Journal of Medical Genetics, 2020
- Deep brain stimulation is effective in pediatric patients with GNAO1 associated severe hyperkinesiaJournal of the Neurological Sciences, 2018
- A mechanistic review on GNAO1-associated movement disorderNeurobiology of Disease, 2018
- Identification of a submicroscopic 3.2 Mb chromosomal 16q12.2‐13 deletion in a child with short stature, mild developmental delay, and craniofacial anomalies, by high‐density oligonucleotide array‐a recognizable syndromeAmerican Journal of Medical Genetics Part A, 2010